Fundz

Arthro Meda, Inc. reported raising $1.91 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATESep 03, 2021$1.9M of $2M raised

Amount Raised

$1.91 Million

$1.91 Million sold, per SEC Form D (first sale Sep 3, 2021)

Round Type

Seed

LowellHealthcareHealth Care

Quick answer

ArthroMeda raised $1.91 Million in a Seed round, dated September 3, 2021. ArthroMeda is based in Lowell, Massachusetts, United States.

How much did ArthroMeda raise?
ArthroMeda raised $1.91 Million in a Seed round on September 3, 2021.
What does ArthroMeda do?
ArthroMeda is revolutionizing orthopedic surgery with innovative, cost-effective tools that enhance precision in implant alignment and fit.
Where is ArthroMeda based and how big is it?
ArthroMeda is based in Lowell, Massachusetts, United States. Fundz records about 3 employees.
Who are the decision-makers at ArthroMeda?
Fundz holds 1 contact at ArthroMeda, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as ArthroMeda that raised within 45 days of this round, from Fundz verified event records.

  • Deinde Medical raised $2.5M on October 15, 2021.
  • Accolade raised $11M on October 15, 2021.
  • Axial Therapeutics raised $37M (Series C) on October 13, 2021.
  • Akadeum Life Sciences raised $18M (Funding Round) on October 12, 2021.
  • Accure Acne raised $2M on October 8, 2021.
  • Embr Labs, Inc raised $6M on October 7, 2021.

Who to call at ArthroMeda, and when

A new round usually means ArthroMeda is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ArthroMeda raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ArthroMeda, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ArthroMeda. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ArthroMeda

Location

172 MIDDLE STREET

Lowell, Massachusetts, United States

About

ArthroMeda is revolutionizing orthopedic surgery with innovative, cost-effective tools that enhance precision in implant alignment and fit. Utilizing micro-sensors, wireless technologies, and custom software applications, ArthroMeda provides real-time data to improve surgical accuracy, ultimately leading to better patient outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ArthroMeda raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPJ A., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ArthroMeda's next move

See what Strategic adds

ArthroMeda raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.